Hospitals dealing with influx of kids with respiratory illnesses
Watch CBS News
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
Watch CBS News
The new year is bringing a surge in cases of RSV and the flu among kids. Hospitals across the country are dealing with a surge in cases and, in some cases, a lack of beds. Janet Shamlian reports.
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
Hospitals face rising cases of respiratory illnesses – CBS News Watch CBS News Hospitals across the country are dealing with higher cases of COVID-19, the flu and RSV. The increase is being fueled in part by holiday travel and gatherings. Meg Oliver has the latest. Be the first to know Get browser notifications for breaking…
A lot of us know someone who has felt pretty rough with the most recent form of the virus.
Asking for a Friend is BuzzFeed News’ health advice column. Ask us anything about your body! If you’re too afraid to google or too embarrassed to ask a friend or family member, let alone a doctor, submit your questions here. Dear Asking for a Friend, I can’t breathe through my nose very well when I’m…
People walk past a billboard advertisement for YouTube in Berlin, Germany, on Sept. 27, 2019. Sean Gallup | Getty Images YouTube is taking steps to fight against medical misinformation, especially when it comes to finding immediate tips on how to handle an emergency. The company on Wednesday introduced a feature called First Aid Information Shelves,…
Drugmaker Eli Lilly announced on Thursday a new website that will allow patients to get a weight loss drug prescription through a telehealth provider — a move, the company says, that will improve access to the extremely popular and effective drugs, including its recently approved drug, Zepbound. The new website, called LillyDirect, joins a growing list of platforms like Weight…
Investor optimism for Eli Lilly ‘s diabetes and obesity treatments in 2023 lifted the stock to its seventh annual gain in a row. In the new year, it should be the same old story. Shares of Eli Lilly have taken a breather over the past three months, as investors book profits in the top performer…